Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% below average
Average (39q)
28.88%
Historical baseline
Range
High:1660.00%
Low:-100.00%
Volatility
6094.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | -100.00% |
| Q3 2022 | -75.37% |
| Q2 2022 | -93.89% |
| Q1 2022 | 134.57% |
| Q4 2021 | -54.00% |
| Q3 2021 | 266.28% |
| Q2 2021 | -49.11% |
| Q1 2021 | -15.38% |
| Q4 2020 | -21.42% |
| Q3 2020 | -51.03% |
| Q2 2020 | 89.09% |
| Q1 2020 | 112.62% |
| Q4 2019 | -4.89% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | -93.94% |
| Q3 2017 | 1660.00% |
| Q2 2017 | -6.25% |
| Q1 2017 | -95.74% |
| Q4 2016 | -8.96% |
| Q3 2016 | 0.00% |
| Q2 2016 | -31.28% |
| Q1 2016 | -81.38% |
| Q4 2015 | -24.85% |